Clinical Trials Browser

Phase 1/2 × HER2-negative Early Breast Cancer × Breast × Clear all

NCT04836156 2022-04-06

Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for Human Epidermal Growth Factor Receptor 2 (HER2) Negative Early Breast Cancer Patients

Phase 1/2 Recruiting

HER2-negative Early Breast Cancer